BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 17169648)

  • 21. Long-term results of radical prostatectomy in clinically localized prostate cancer: experience at the Johns Hopkins Hospital.
    Lepor H; Walsh PC
    NCI Monogr; 1988; (7):117-22. PubMed ID: 3173497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of conservative management of clinically localized prostate cancer.
    Chodak GW; Thisted RA; Gerber GS; Johansson JE; Adolfsson J; Jones GW; Chisholm GD; Moskovitz B; Livne PM; Warner J
    N Engl J Med; 1994 Jan; 330(4):242-8. PubMed ID: 8272085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should we treat localized prostate cancer? An opinion.
    Menon M; Parulkar BG; Baker S
    Urology; 1995 Nov; 46(5):607-16. PubMed ID: 7495109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.
    Elliott SP; Meng MV; Elkin EP; McAninch JW; Duchane J; Carroll PR;
    J Urol; 2007 Aug; 178(2):529-34; discussion 534. PubMed ID: 17570425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer.
    Sanderson KM; Penson DF; Cai J; Groshen S; Stein JP; Lieskovsky G; Skinner DG
    J Urol; 2006 Nov; 176(5):2025-31; discussion 2031-2. PubMed ID: 17070244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
    Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.
    Bastian PJ; Palapattu GS; Yegnasubramanian S; Lin X; Rogers CG; Mangold LA; Trock B; Eisenberger M; Partin AW; Nelson WG
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5361-7. PubMed ID: 17875764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival of men with clinically localized prostate cancer treated with prostatectomy, brachytherapy, or no definitive treatment: impact of age at diagnosis.
    Tward JD; Lee CM; Pappas LM; Szabo A; Gaffney DK; Shrieve DC
    Cancer; 2006 Nov; 107(10):2392-400. PubMed ID: 17041884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.
    Walz J; Gallina A; Saad F; Montorsi F; Perrotte P; Shariat SF; Jeldres C; Graefen M; Bénard F; McCormack M; Valiquette L; Karakiewicz PI
    J Clin Oncol; 2007 Aug; 25(24):3576-81. PubMed ID: 17704404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Major 30-day complications after radical radiotherapy: a population-based analysis and comparison with surgery.
    Alibhai SM; Leach M; Warde P
    Cancer; 2009 Jan; 115(2):293-302. PubMed ID: 19025976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of second treatment following definitive local therapy for prostate cancer: data from the caPSURE database.
    Grossfeld GD; Stier DM; Flanders SC; Henning JM; Schonfeld W; Warolin K; Carroll PR
    J Urol; 1998 Oct; 160(4):1398-404. PubMed ID: 9751363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited pelvic lymph node dissection does not improve biochemical relapse-free survival at 10 years after radical prostatectomy in patients with low-risk prostate cancer.
    Weight CJ; Reuther AM; Gunn PW; Zippe CR; Dhar NB; Klein EA
    Urology; 2008 Jan; 71(1):141-5. PubMed ID: 18242383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
    Sengupta S; Blute ML; Bagniewski SM; Inman B; Leibovich BC; Slezak JM; Myers RP; Zincke H
    BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radical prostatectomy for clinical stage T3a disease.
    Freedland SJ; Partin AW; Humphreys EB; Mangold LA; Walsh PC
    Cancer; 2007 Apr; 109(7):1273-8. PubMed ID: 17315165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer.
    Joslyn SA; Konety BR
    Urology; 2006 Jul; 68(1):121-5. PubMed ID: 16806432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer-specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factors.
    D'Amico AV; Chen MH; Catalona WJ; Sun L; Roehl KA; Moul JW
    Cancer; 2007 Jul; 110(1):56-61. PubMed ID: 17530618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era.
    Kibel AS; Ciezki JP; Klein EA; Reddy CA; Lubahn JD; Haslag-Minoff J; Deasy JO; Michalski JM; Kallogjeri D; Piccirillo JF; Rabah DM; Yu C; Kattan MW; Stephenson AJ
    J Urol; 2012 Apr; 187(4):1259-65. PubMed ID: 22335870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radical prostatectomy for high-grade prostate cancer.
    Hurwitz MD; Schultz D; Richie JP; Wein AJ; Whittington R; Malkowicz SB; D'Amico AV
    Urology; 2006 Aug; 68(2):367-70. PubMed ID: 16904454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nomogram underestimates 10-year survival in healthy men selected for radical prostatectomy at age 70 years or older.
    Froehner M; Koch R; Litz RJ; Wirth MP
    Urology; 2009 Mar; 73(3):610-3; discussion 613-4. PubMed ID: 19167030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.